(Q37724173)

22 August 2017

1 reference

title

Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages (English)

1 reference

22 August 2017

1 reference

Shibashish Giri

1

1 reference

22 August 2017

Karen Nieber

series ordinal

2

1 reference

22 August 2017

Augustinus Bader

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Expert Opinion on Drug Metabolism & Toxicology

22 August 2017

published in

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

895-917

1 reference

Policy developments in regulatory approval

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Cellular imaging predictions of clinical drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Liver transplantation for acute liver failure from drug induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Epidemiology and individual susceptibility to adverse drug reactions affecting the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Role of pharmacologically active metabolites in drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity associated with acarbose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Intrahepatic Obstructive Jaundice from Amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute Hepatic Necrosis Following Treatment with Amitriptyline and Diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Amitriptyline-induced fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Nortriptyline-induced hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute liver failure due to amoxicillin and amoxicillin/clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Amoxicillin-clavulanic acid-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hypersensitivity to clavulanic acid in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Cholestatic hepatitis associated with clavulanic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Fulminant hepatic failure due to allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Amiodarone-induced liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Mechanisms of benzarone and benzbromarone-induced hepatic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Development and characterization of an animal model of carnitine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity associated with amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Low dose amiodarone causing pseudo-alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatic cirrhosis caused by low-dose oral amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Can Pancreatitis Be Associated with Amiodarone Hepatotoxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Consequences of use of anabolic androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity associated with dietary supplements containing anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatocellular carcinoma associated with recreational anabolic steroid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Peliosis hepatis in recipients of renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Cholestatic jaundice associated with captopril therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Captopril-induced jaundice: report of 2 cases and a review of 13 additional reports in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Jaundice during cyproheptadine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clindamycin-induced acute cholestatic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clindamycin-associated hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clindamycin in the Treatment of Serious Anaerobic Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clindamycin and benzoyl peroxide combined was more effective than either agent alone or placebo for acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Granulomatous hepatitis secondary to carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Carbamazepine-induced acute cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute liver failure induced by carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

JAUNDICE AND ITS RELATION TO THERAPEUTIC AGENTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Letter: Oral contraceptives and benign liver tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatobiliary complications of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Liver tumor in long-term user of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clopidogrel-induced hepatotoxicity and fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity induced by clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatitis from dantrolene sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Dantrolene sodium and hepatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Disulfiram-induced fulminant hepatic failure in an active duty soldier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clinical characteristics and prognostic markers in disulfiram-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Disulfiram Hypersensitivity Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Disulfiram-induced hepatitis. Report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Disulfiram-induced hepatitis. Report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Dihydralazine hepatitis: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute liver failure due to enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Fatal hepatotoxicity associated with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Ductopenic hepatitis related to Enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Fulminant hepatitis after flutamide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Flutamide-induced liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity of antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Chronic hepatic inflammation and fibrosis due to low doses of paracetamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Deaths from low dose paracetamol poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acetaminophen-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

21 January 2018

Sulindac hepatotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Nonsteroidal anti-inflammatory drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute hepatitis attack after exposure to telithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Telithromycin use and spontaneous reports of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatic side-effects of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Antibacterial-induced hepatotoxicity. Incidence, prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Effect of tetracycline on pancreas and liver function of adult male albino rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Drug-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Comparative tolerability of the newer fluoroquinolone antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Trovafloxacin hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Trazodone-induced hepatotoxicity and leukonychia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Fatal hepatic necrosis associated with trazodone and neuroleptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity after short-term trazodone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Sulfamethoxazole/Trimethoprim induced liver failure: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatitis associated with terbinafine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Drug-induced liver injury associated with statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Nicardipine-induced acute hepatitis in an intensive care unit patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Sirolimus-associated hepatotoxicity in the kidney graft recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Sirolimus-associated hepatotoxicity in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Case report: fatal hepatic failure after aortic valve replacement and sevoflurane exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

A fatal case of fulminant hepatic necrosis following sevoflurane anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

A case of valerian-associated hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Acute hepatitis due to fluoxetine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity of pyrazinamide: cohort and case-control analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatotoxicity of antibiotics and antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Role of Covalent and Noncovalent Interactions in Cell Toxicity: Effects on Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

The immunologic and metabolic basis of drug hypersensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Induction of phase I, II and III drug metabolism/transport by xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Two compartment model of diazepam biotransformation in an organotypical culture of primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

New analytical strategies in studying drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Drug metabolism in hepatocyte sandwich cultures of rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

The stimulation and inhibition of hepatic microsomal drug-metabolizing enzymes with special reference to effects of environmental contaminants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Determinants of Metabolite Disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Membrane transport as a determinant of the hepatic elimination of drugs and metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Clearing the MIST (metabolites in safety testing) of time: The impact of duration of administration on drug metabolite toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Liver pathology associated with the use of anabolic-androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Bromfenac (Duract)-associated hepatic failure requiring liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

21 January 2018

Flutamide Hepatotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425251003792521

10.1517/17425251003792521

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference